Copyright Reports & Markets. All rights reserved.

Global and United States Prostate Cancer Screening Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Prostate Cancer Screening Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Physical Exam
    • 1.2.3 Laboratory Tests
    • 1.2.4 Imaging Tests
    • 1.2.5 Gleason Score
    • 1.2.6 TNM Score
    • 1.2.7 Genetic Tests
    • 1.2.8 Digital Rectal Exam
    • 1.2.9 Biopsy
  • 1.3 Market by Application
    • 1.3.1 Global Prostate Cancer Screening Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Research Labs
    • 1.3.5 Cancer Institutes
    • 1.3.6 Diagnostic Centers
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Prostate Cancer Screening Market Perspective (2015-2026)
  • 2.2 Global Prostate Cancer Screening Growth Trends by Regions
    • 2.2.1 Prostate Cancer Screening Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Prostate Cancer Screening Historic Market Share by Regions (2015-2020)
    • 2.2.3 Prostate Cancer Screening Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Prostate Cancer Screening Players by Market Size
    • 3.1.1 Global Top Prostate Cancer Screening Players by Revenue (2015-2020)
    • 3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2015-2020)
  • 3.2 Global Prostate Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Prostate Cancer Screening Revenue
  • 3.4 Global Prostate Cancer Screening Market Concentration Ratio
    • 3.4.1 Global Prostate Cancer Screening Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Screening Revenue in 2019
  • 3.5 Key Players Prostate Cancer Screening Area Served
  • 3.6 Key Players Prostate Cancer Screening Product Solution and Service
  • 3.7 Date of Enter into Prostate Cancer Screening Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Screening Breakdown Data by Type (2015-2026)

  • 4.1 Global Prostate Cancer Screening Historic Market Size by Type (2015-2020)
  • 4.2 Global Prostate Cancer Screening Forecasted Market Size by Type (2021-2026)

5 Prostate Cancer Screening Breakdown Data by Application (2015-2026)

  • 5.1 Global Prostate Cancer Screening Historic Market Size by Application (2015-2020)
  • 5.2 Global Prostate Cancer Screening Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Prostate Cancer Screening Market Size (2015-2026)
  • 6.2 North America Prostate Cancer Screening Market Size by Type (2015-2020)
  • 6.3 North America Prostate Cancer Screening Market Size by Application (2015-2020)
  • 6.4 North America Prostate Cancer Screening Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Prostate Cancer Screening Market Size (2015-2026)
  • 7.2 Europe Prostate Cancer Screening Market Size by Type (2015-2020)
  • 7.3 Europe Prostate Cancer Screening Market Size by Application (2015-2020)
  • 7.4 Europe Prostate Cancer Screening Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Prostate Cancer Screening Market Size (2015-2026)
  • 8.2 China Prostate Cancer Screening Market Size by Type (2015-2020)
  • 8.3 China Prostate Cancer Screening Market Size by Application (2015-2020)
  • 8.4 China Prostate Cancer Screening Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Prostate Cancer Screening Market Size (2015-2026)
  • 9.2 Japan Prostate Cancer Screening Market Size by Type (2015-2020)
  • 9.3 Japan Prostate Cancer Screening Market Size by Application (2015-2020)
  • 9.4 Japan Prostate Cancer Screening Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Prostate Cancer Screening Market Size (2015-2026)
  • 10.2 Southeast Asia Prostate Cancer Screening Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Prostate Cancer Screening Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Prostate Cancer Screening Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Prostate Cancer Screening Introduction
    • 11.1.4 Abbott Laboratories Revenue in Prostate Cancer Screening Business (2015-2020))
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Almac
    • 11.2.1 Almac Company Details
    • 11.2.2 Almac Business Overview
    • 11.2.3 Almac Prostate Cancer Screening Introduction
    • 11.2.4 Almac Revenue in Prostate Cancer Screening Business (2015-2020)
    • 11.2.5 Almac Recent Development
  • 11.3 Bayer
    • 11.3.1 Bayer Company Details
    • 11.3.2 Bayer Business Overview
    • 11.3.3 Bayer Prostate Cancer Screening Introduction
    • 11.3.4 Bayer Revenue in Prostate Cancer Screening Business (2015-2020)
    • 11.3.5 Bayer Recent Development
  • 11.4 Beckman Coulter
    • 11.4.1 Beckman Coulter Company Details
    • 11.4.2 Beckman Coulter Business Overview
    • 11.4.3 Beckman Coulter Prostate Cancer Screening Introduction
    • 11.4.4 Beckman Coulter Revenue in Prostate Cancer Screening Business (2015-2020)
    • 11.4.5 Beckman Coulter Recent Development
  • 11.5 BioméRieux
    • 11.5.1 BioméRieux Company Details
    • 11.5.2 BioméRieux Business Overview
    • 11.5.3 BioméRieux Prostate Cancer Screening Introduction
    • 11.5.4 BioméRieux Revenue in Prostate Cancer Screening Business (2015-2020)
    • 11.5.5 BioméRieux Recent Development
  • 11.6 Genomic Health
    • 11.6.1 Genomic Health Company Details
    • 11.6.2 Genomic Health Business Overview
    • 11.6.3 Genomic Health Prostate Cancer Screening Introduction
    • 11.6.4 Genomic Health Revenue in Prostate Cancer Screening Business (2015-2020)
    • 11.6.5 Genomic Health Recent Development
  • 11.7 Mayo Clinic
    • 11.7.1 Mayo Clinic Company Details
    • 11.7.2 Mayo Clinic Business Overview
    • 11.7.3 Mayo Clinic Prostate Cancer Screening Introduction
    • 11.7.4 Mayo Clinic Revenue in Prostate Cancer Screening Business (2015-2020)
    • 11.7.5 Mayo Clinic Recent Development
  • 11.8 Mdxhealth
    • 11.8.1 Mdxhealth Company Details
    • 11.8.2 Mdxhealth Business Overview
    • 11.8.3 Mdxhealth Prostate Cancer Screening Introduction
    • 11.8.4 Mdxhealth Revenue in Prostate Cancer Screening Business (2015-2020)
    • 11.8.5 Mdxhealth Recent Development
  • 11.9 Roche Diagnostics
    • 11.9.1 Roche Diagnostics Company Details
    • 11.9.2 Roche Diagnostics Business Overview
    • 11.9.3 Roche Diagnostics Prostate Cancer Screening Introduction
    • 11.9.4 Roche Diagnostics Revenue in Prostate Cancer Screening Business (2015-2020)
    • 11.9.5 Roche Diagnostics Recent Development
  • 11.10 Rosetta Genomics
    • 11.10.1 Rosetta Genomics Company Details
    • 11.10.2 Rosetta Genomics Business Overview
    • 11.10.3 Rosetta Genomics Prostate Cancer Screening Introduction
    • 11.10.4 Rosetta Genomics Revenue in Prostate Cancer Screening Business (2015-2020)
    • 11.10.5 Rosetta Genomics Recent Development
  • 11.11 Thermo Fisher Scientific
    • 10.11.1 Thermo Fisher Scientific Company Details
    • 10.11.2 Thermo Fisher Scientific Business Overview
    • 10.11.3 Thermo Fisher Scientific Prostate Cancer Screening Introduction
    • 10.11.4 Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2015-2020)
    • 10.11.5 Thermo Fisher Scientific Recent Development
  • 11.12 Hologic
    • 10.12.1 Hologic Company Details
    • 10.12.2 Hologic Business Overview
    • 10.12.3 Hologic Prostate Cancer Screening Introduction
    • 10.12.4 Hologic Revenue in Prostate Cancer Screening Business (2015-2020)
    • 10.12.5 Hologic Recent Development
  • 11.13 Myriad Genetics
    • 10.13.1 Myriad Genetics Company Details
    • 10.13.2 Myriad Genetics Business Overview
    • 10.13.3 Myriad Genetics Prostate Cancer Screening Introduction
    • 10.13.4 Myriad Genetics Revenue in Prostate Cancer Screening Business (2015-2020)
    • 10.13.5 Myriad Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Prostate Cancer Screening Scope and Market Size
    Prostate Cancer Screening market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Physical Exam
    Laboratory Tests
    Imaging Tests
    Gleason Score
    TNM Score
    Genetic Tests
    Digital Rectal Exam
    Biopsy

    Market segment by Application, split into
    Hospitals
    Clinics
    Research Labs
    Cancer Institutes
    Diagnostic Centers
    Others

    Based on regional and country-level analysis, the Prostate Cancer Screening market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Prostate Cancer Screening market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott Laboratories
    Almac
    Bayer
    Beckman Coulter
    BioméRieux
    Genomic Health
    Mayo Clinic
    Mdxhealth
    Roche Diagnostics
    Rosetta Genomics
    Thermo Fisher Scientific
    Hologic
    Myriad Genetics

    Buy now